#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Bringing Access to the Full Spectrum of Cancer Research: A Call for Papers


article has not abstract


Vyšlo v časopise: Bringing Access to the Full Spectrum of Cancer Research: A Call for Papers. PLoS Med 12(4): e32767. doi:10.1371/journal.pmed.1001817
Kategorie: Editorial
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001817

Souhrn

article has not abstract


Zdroje

1. Stewart BW, Wild CP, editors (2014) World Cancer Report 2014. http://www.iarc.fr/en/publications/books/wcr/index.php. International Agency for Research on Cancer.

2. US FDA (2015) Hematology/Oncology (Cancer) Approvals & Safety Notifications. http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm. Accessed 17 March 2015.

3. Schwarz RF, Ng CKY, Cooke SL, Newman S, Temple J, et al. (2015) Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis. PLoS Med 12(2): e1001789. doi: 10.1371/journal.pmed.1001789 25710373

4. Mroz EA, Tward AM, Hammon RJ, Ren Y, Rocco JW (2015) Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas. PLoS Med 12(2): e1001786. doi: 10.1371/journal.pmed.1001786 25668320

5. Gupta S, Rivera-Luna R, Ribeiro RC, Howard SC (2014) Pediatric Oncology as the Next Global Child Health Priority: The Need for National Childhood Cancer Strategies in Low- and Middle-Income Countries PLoS Med 11: e1001656. doi: 10.1371/journal.pmed.1001656 24936984

6. Singhrao R, Huchko M, Yamey G (2013) Reproductive and Maternal Health in the Post-2015 Era: Cervical Cancer Must Be a Priority. PLOS Med 10: e1001499. doi: 10.1371/journal.pmed.1001499 23966840

7. Forrest LF, Adams J, Wareham H, Rubin G, White M (2013) Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis. PLoS Med 10(2): e1001376. doi: 10.1371/journal.pmed.1001376 23393428

8. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, et al. (2014) Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies. PLoS Med 11(7): e1001673. doi: 10.1371/journal.pmed.1001673 25003901

9. Ulucanlar S, Fooks GJ, Hatchard JL, Gilmore AB (2014) Representation and Misrepresentation of Scientific Evidence in Contemporary Tobacco Regulation: A Review of Tobacco Industry Submissions to the UK Government Consultation on Standardised Packaging. PLoS Med 11(3): e1001629. doi: 10.1371/journal.pmed.1001629 24667150

10. Zheng W, McLerran DF, Rolland BA, Fu Z, Boffetta P, et al. (2014) Burden of Total and Cause-Specific Mortality Related to Tobacco Smoking among Adults Aged ≥45 Years in Asia: A Pooled Analysis of 21 Cohorts. PLoS Med 11(4): e1001631. doi: 10.1371/journal.pmed.1001631 24756146

11. Singal AG, Pillai A, Tiro J (2014) Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis. PLoS Med 11(4): e1001624. doi: 10.1371/journal.pmed.1001624 24691105

12. Castañón A, Landy R, Cuzick J, Sasieni P (2014) Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study. PLoS Med 11(1): e1001585. doi: 10.1371/journal.pmed.1001585 24453946

13. Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, et al. (2014) Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts. PLoS Med 11(12): e1001764. doi: 10.1371/journal.pmed.1001764 25460915

14. Ross-Innes CS, Debiram-Beecham I, O'Donovan M, Walker E, Varghese S, et al. (2015) Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study. PLoS Med 12(1): e1001780. doi: 10.1371/journal.pmed.1001780 25634542

15. Kim JH, Sohn BH, Lee H-S, Kim S-B, Yoo JE, et al. (2014) Genomic Predictors for Recurrence Patterns of Hepatocellular Carcinoma: Model Derivation and Validation. PLoS Med 11(12): e1001770. doi: 10.1371/journal.pmed.1001770 25536056

16. Martinez-Torres A-C, Quiney C, Attout T, Boullet H, Herbi L, et al. (2015) CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans. PLoS Med 12(3): e1001796. doi: 10.1371/journal.pmed.1001796 25734483

17. Eng A, McCormack V, dos-Santos-Silva I (2014) Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis. PLoS Med 11(9): e1001720. doi: 10.1371/journal.pmed.1001720 25202974

18. Beck AH (2015) Open Access to Large Scale Datasets Is Needed to Translate Knowledge of Cancer Heterogeneity into Better Patient Outcomes. PLoS Med 12(2): e1001794. doi: 10.1371/journal.pmed.1001794 25710538

19. PLOS Medicine Editors (2015 Apr 17) Cancer genomics: data, data and more data. In: Speaking of Medicine Blog. Available: http://blogs.plos.org/speakingofmedicine/2015/04/17/interview-francis-ouellette/

20. PLOS Medicine Editors (2015) Cancer Research Collection homepage. Available: www.ploscollections.org/plosmedicinecancerreasearch

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2015 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#